GSK announces regulatory submission for umeclidinium monotherapy for COPD in Japan

GSK announced the submission of a regulatory application to the Japanese MHLW for UMEC a LAMA, administered using the Ellipta™ dry powder inhaler.
Source: GSK news - Category: Pharmaceuticals Source Type: news